224 related articles for article (PubMed ID: 19903806)
1. A new generation of studies of human papillomavirus DNA testing in cervical cancer screening.
Franco EL
J Natl Cancer Inst; 2009 Dec; 101(23):1600-1. PubMed ID: 19903806
[No Abstract] [Full Text] [Related]
2. Preventing cervical cancer globally by acting locally: if not now, when?
Gage JC; Castle PE
J Natl Cancer Inst; 2010 Oct; 102(20):1524-7. PubMed ID: 20884892
[No Abstract] [Full Text] [Related]
3. Re: Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
Lynge E; Rebolj M
J Natl Cancer Inst; 2010 May; 102(10):739; author reply 739-40. PubMed ID: 20360534
[No Abstract] [Full Text] [Related]
4. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
[TBL] [Abstract][Full Text] [Related]
5. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.
Ronco G; Giorgi-Rossi P; Carozzi F; Confortini M; Dalla Palma P; Del Mistro A; Gillio-Tos A; Minucci D; Naldoni C; Rizzolo R; Schincaglia P; Volante R; Zappa M; Zorzi M; Cuzick J; Segnan N;
J Natl Cancer Inst; 2008 Apr; 100(7):492-501. PubMed ID: 18364502
[TBL] [Abstract][Full Text] [Related]
6. Is it time to introduce HPV self-sampling for primary cervical cancer screening?
Petignat P; Vassilakos P
J Natl Cancer Inst; 2012 Feb; 104(3):166-7. PubMed ID: 22271766
[No Abstract] [Full Text] [Related]
7. Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial.
Denny L; Kuhn L; Hu CC; Tsai WY; Wright TC
J Natl Cancer Inst; 2010 Oct; 102(20):1557-67. PubMed ID: 20884893
[TBL] [Abstract][Full Text] [Related]
8. HPV testing in cervical screening.
Cuzick J
Pharmacoepidemiol Drug Saf; 2001; 10(1):33-6. PubMed ID: 11417064
[No Abstract] [Full Text] [Related]
9. Expanded use of human papillomavirus testing in gynecologic practice.
Day S; Garces J
Am J Clin Pathol; 2007 Nov; 128(5):886-8; author reply 888-90. PubMed ID: 18018332
[No Abstract] [Full Text] [Related]
10. Re: Preventing cervical cancer globally by acting locally: if not now, when?
Suba EJ; Michelow PM; Wright CA; Raab SS
J Natl Cancer Inst; 2011 Apr; 103(7):611-2; author reply 612-3. PubMed ID: 21451154
[No Abstract] [Full Text] [Related]
11. [The HPV test in primary cervical cancer screening].
Bergeron C
Ann Pathol; 2008 Nov; 28 Spec No 1(1):S90-1. PubMed ID: 18984315
[No Abstract] [Full Text] [Related]
12. HPV primary screening for cervical cancer: more pain than protection.
Davey DD; Armenti CA
Diagn Cytopathol; 2000 Jun; 22(6):333-5. PubMed ID: 10820524
[No Abstract] [Full Text] [Related]
13. Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method.
Zhao FH; Lewkowitz AK; Chen F; Lin MJ; Hu SY; Zhang X; Pan QJ; Ma JF; Niyazi M; Li CQ; Li SM; Smith JS; Belinson JL; Qiao YL; Castle PE
J Natl Cancer Inst; 2012 Feb; 104(3):178-88. PubMed ID: 22271765
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.
Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Forslund O; Hansson BG; Hagmar B; Johansson B; Rylander E; Dillner J
J Natl Cancer Inst; 2009 Jan; 101(2):88-99. PubMed ID: 19141778
[TBL] [Abstract][Full Text] [Related]
15. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India.
Arbyn M; Sankaranarayanan R; Muwonge R; Keita N; Dolo A; Mbalawa CG; Nouhou H; Sakande B; Wesley R; Somanathan T; Sharma A; Shastri S; Basu P
Int J Cancer; 2008 Jul; 123(1):153-60. PubMed ID: 18404671
[TBL] [Abstract][Full Text] [Related]
16. Persistent HPV infection and cervical cancer risk: is the scientific rationale for changing the screening paradigm enough?
Franco EL
J Natl Cancer Inst; 2010 Oct; 102(19):1451-3. PubMed ID: 20841606
[No Abstract] [Full Text] [Related]
17. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial.
Ronco G; Segnan N; Giorgi-Rossi P; Zappa M; Casadei GP; Carozzi F; Dalla Palma P; Del Mistro A; Folicaldi S; Gillio-Tos A; Nardo G; Naldoni C; Schincaglia P; Zorzi M; Confortini M; Cuzick J;
J Natl Cancer Inst; 2006 Jun; 98(11):765-74. PubMed ID: 16757701
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus testing in the prevention of cervical cancer.
Schiffman M; Wentzensen N; Wacholder S; Kinney W; Gage JC; Castle PE
J Natl Cancer Inst; 2011 Mar; 103(5):368-83. PubMed ID: 21282563
[TBL] [Abstract][Full Text] [Related]
20. Time to consider HPV testing in cervical screening.
Cuzick J
Ann Oncol; 2001 Nov; 12(11):1511-4. PubMed ID: 11822748
[No Abstract] [Full Text] [Related]
[Next] [New Search]
